Vir Biotechnology Inc (NASDAQ: VIR) started the day on Wednesday, with a price increase of 3.15% at $7.86, before settling in for the price of $7.62 at the close. Taking a more long-term approach, VIR posted a 52-week range of $6.56-$13.09.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 421.39% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -34.12%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 14.45%. This publicly-traded company’s shares outstanding now amounts to $134.78 million, simultaneously with a float of $87.31 million. The organization now has a market capitalization sitting at $1.12 billion. At the time of writing, stock’s 50-day Moving Average stood at $7.89, while the 200-day Moving Average is $9.13.
Vir Biotechnology Inc (VIR) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Vir Biotechnology Inc’s current insider ownership accounts for 36.61%, in contrast to 49.44% institutional ownership. According to the most recent insider trade that took place on Nov 06 ’24, this organization’s EVP and General Counsel sold 4,397 shares at the rate of 10.11, making the entire transaction reach 44,454 in total value, affecting insider ownership by 56,973.
Vir Biotechnology Inc (VIR) Earnings and Revenue Records
Vir Biotechnology Inc’s EPS increase for this current 12-month fiscal period is 14.45% and is forecasted to reach -3.81 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 7.00% through the next 5 years, which can be compared against the -34.12% growth it accomplished over the previous five years trading on the market.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Let’s observe the current performance indicators for Vir Biotechnology Inc (VIR). It’s Quick Ratio in the last reported quarter now stands at 8.94. The Stock has managed to achieve an average true range (ATR) of 0.52. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 14.20.
In the same vein, VIR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.92, a figure that is expected to reach -0.87 in the next quarter, and analysts are predicting that it will be -3.81 at the market close of one year from today.
Technical Analysis of Vir Biotechnology Inc (VIR)
If we take a close look at the recent performances of Vir Biotechnology Inc (NASDAQ: VIR), its last 5-days Average volume was 1.21 million that shows progress from its year to date volume of 1.04 million. During the previous 9 days, stock’s Stochastic %D was recorded 44.31% While, its Average True Range was 0.54.
Raw Stochastic average of Vir Biotechnology Inc (VIR) in the period of the previous 100 days is set at 29.28%, which indicates a major fall in contrast to 36.47% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 76.45% that was higher than 61.29% volatility it exhibited in the past 100-days period.
